CenSyn
Pre Seed Round in 2022
CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.
Zeto Inc. is a medical technology company based in Santa Clara, California, focused on revolutionizing electroencephalography (EEG) practices in hospitals. Established in 2014, Zeto has developed an innovative dry electrode EEG system that features a wireless, easy-to-wear headset designed to enhance patient experience and streamline the EEG process. This system is the first of its kind to receive FDA clearance, eliminating the need for extensive preparation and specialized technicians. It significantly reduces setup time from over 30 minutes to just five, allowing for quicker and more efficient EEG interpretation. The accompanying digital platform offers instant data upload, live viewing capabilities, and analytical tools, enabling remote analysis by neurologists. Zeto has gained recognition for its advancements in EEG technology, receiving multiple awards, including funding from the Epilepsy Foundation and accolades for innovation in medical technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.